Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “dose”

70 pharma patents match "dose" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 70
Index total 30,257
Page 2 / 3

Quick answer

This filtered view shows 70 pharmaceutical patents matching "dose" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

70 results for “dose” · 30,257 patents in full index Clear search

  1. US 11123334

    Compositions and methods for treating opioid overdose and opioid abuse

    The Board of Regents of the University of Texas System · Granted Sep 21, 2021 · Expires Sep 16, 2041

    granted

  2. US 11090269

    Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances

    Jazz Pharmaceuticals, Inc. · Granted Aug 17, 2021 · Expires Aug 12, 2041

    granted

  3. US 11090326

    Fixed-dose pharmaceutical composition comprising rifabutin, clarithromycin, and clofazimine

    RedHill Biopharma Ltd. · Granted Aug 17, 2021 · Expires Aug 12, 2041

    granted

  4. US 10987310

    Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances

    Jazz Pharmaceuticals, Inc. · Granted Apr 27, 2021 · Expires Apr 22, 2041

    granted

  5. CN 112638413

    Oral immunotherapy unit dose dispensing systems and methods

    ALLERGEN RES CORPORATION · Granted Apr 9, 2021 · Expires Apr 4, 2041

    granted

  6. US 10966931

    Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances

    Jazz Pharmaceuticals, Inc. · Granted Apr 6, 2021 · Expires Apr 1, 2041

    granted

  7. US 10960016

    Capsules containing high doses of krill phospholipids

    AKER BIOMARINE ANTARCTIC AS · Granted Mar 30, 2021 · Expires Mar 25, 2041

    granted

  8. US 10959956

    Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances

    Jazz Pharmaceuticals, Inc. · Granted Mar 30, 2021 · Expires Mar 25, 2041

    granted

  9. US 10912751

    Fixed dose combinations and formulations comprising ETC1002 and ezetimibe and methods of treating or reducing the risk of cardiovascular disease

    Esperion Therapeutics, Inc. · Granted Feb 9, 2021 · Expires Feb 4, 2041

    granted

  10. US 10849911

    Low dose compositions of Aramachol salts

    GALMED RESEARCH AND DEVELOPMENT LTD · Granted Dec 1, 2020 · Expires Nov 26, 2040

    granted

  11. US 10842814

    Use of low dose arsenic for preserving genomic integrity

    The Board of Regents of the University of Texas System · Granted Nov 24, 2020 · Expires Nov 19, 2040

    granted

  12. US 10813885

    Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances

    Jazz Pharmaceuticals, Inc. · Granted Oct 27, 2020 · Expires Oct 22, 2040

    granted

  13. CA 3131817

    FORMES POSOLOGIQUES D'HORMONE DE CROISSANCE A ACTION PROLONGEE AYANT UNE EFFICACITE SUPERIEURE A UNE DOSE DE SOMATROPINE QUOTIDIENNE

    ASCENDIS PHARMA ENDOCRINOLOGY DIV A/S [DK] · Granted Sep 10, 2020 · Expires Sep 5, 2040

    granted

  14. US 10758488

    Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances

    Jazz Pharmaceuticals, Inc. · Granted Sep 1, 2020 · Expires Aug 27, 2040

    granted

  15. US 10751383

    Doses and methods for administering telavancin

    Cumberland Pharmaceuticals Inc. · Granted Aug 25, 2020 · Expires Aug 20, 2040

    granted

  16. US 10722478

    Methods and compositions for treating fatigue associated with disordered sleep using very low dose cyclobenzaprine

    TONIX PHARMA LIMITED · Granted Jul 28, 2020 · Expires Jul 23, 2040

    granted

  17. US 10668015

    Unit aerosol doses for anticoagulation

    The Regents of the University of California · Granted Jun 2, 2020 · Expires May 28, 2040

    granted

  18. CA 3099620

    DOSE INITIALE DE CONJUGUES DE LA PTH

    ASCENDIS PHARMA BONE DISEASES AS [DK] · Granted Nov 21, 2019 · Expires Nov 16, 2039

    granted

  19. US 10434114

    Methods of treating a bacterial infection using a fixed-dose pharmaceutical composition comprising three antibiotics

    RedHill Biopharma Ltd. · Granted Oct 8, 2019 · Expires Oct 3, 2039

    granted

  20. US 10391152

    Methods of using a fixed dose of a clotting factor

    BIOVERATIV THERAPEUTICS INC. · Granted Aug 27, 2019 · Expires Aug 22, 2039

    granted

  21. US 2019224329

    Incremental Dose Finding in Controlled-Release PTH Compounds

    ASCENDIS PHARMA BONE DISEASES AS [DK] · Granted Jul 25, 2019 · Expires Jul 20, 2039

    granted

  22. US 10335460

    IL-15 and IL-15Rα heterodimer dose escalation regimens for treating conditions

    THE UNITED STATES OF AMERICA, DEPARTMENT OF HEALTH AND HUMAN SERVICES · Granted Jul 2, 2019 · Expires Jun 27, 2039

    granted

  23. US 10300027

    Effective sensitizing dose of a gelled immunomodulating topical composition

    Phio Pharmaceuticals Corp. · Granted May 28, 2019 · Expires May 23, 2039

    granted

  24. US 10143702

    Fixed-dose pharmaceutical composition comprising rifabutin, clarithromycin, and clofazimine

    RedHill Biopharma Ltd. · Granted Dec 4, 2018 · Expires Nov 29, 2038

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.